Literature DB >> 525648

Altered gentamicin distribution in ascitic patients.

M A Gill, J W Kern.   

Abstract

Gentamicin pharmacokinetics were studied in eight patients with ascites. Gentamicin serum levels were measured by radioimmunoassay immediately before, 15 minutes after, and at one and two estimated half-lives after intermittent i.v. infusions of gentamicin. Volumes of distributions (Vd) calculated for the eight patients were significantly larger than mean values reported for the drug in normal patients (p less than 0.025). Vd ranged from 20.2 to 53 liters and correlated poorly with lean and total body weights. In patients with ascites or abnormal extracellular fluid volumes, gentamicin dosage should be based on frequent measurements of serum gentamicin levels and on clinical response.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 525648

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  8 in total

1.  Ascitic fluid and serum cefotaxime and desacetyl cefotaxime levels in patients treated for bacterial peritonitis.

Authors:  B A Runyon; E A Akriviadis; F R Sattler; J Cohen
Journal:  Dig Dis Sci       Date:  1991-12       Impact factor: 3.199

Review 2.  Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.

Authors:  Federico Pea; Pierluigi Viale; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

3.  Variation in the pharmacokinetics of gentamicin and tobramycin in patients with pleural effusions and hypoalbuminemia.

Authors:  J V Etzel; A N Nafziger; J S Bertino
Journal:  Antimicrob Agents Chemother       Date:  1992-03       Impact factor: 5.191

Review 4.  Effect of hepatic insufficiency on pharmacokinetics and drug dosing.

Authors:  R K Verbeeck; Y Horsmans
Journal:  Pharm World Sci       Date:  1998-10

5.  Disposition of cefoxitin in patients with ascites.

Authors:  M J Garcia; A Dominguez-Gil; F D Perez; F P Rodriguez; F D Moronta
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

6.  Comparison of Sawchuk-Zaske and Bayesian forecasting for aminoglycosides in seriously ill patients.

Authors:  C P Denaro; P J Ravenscroft
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

7.  Aminoglycoside forecasting in neutropenic patients with cancer.

Authors:  J L Kosirog; R M Rospond; C Destache; P Hall
Journal:  Clin Pharmacokinet       Date:  1993-01       Impact factor: 6.447

8.  Gentamicin pharmacokinetic changes in induced acute canine nephrotoxic glomerulonephritis.

Authors:  J E Riviere; G L Coppoc; E J Hinsman; W W Carlton
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.